Published in J Gastric Cancer on June 27, 2012
Gastric cancer-molecular and clinical dimensions. Nat Rev Clin Oncol (2013) 1.72
Significance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories. Chin J Cancer Res (2014) 1.41
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas. Gut (2014) 1.14
Adjuvant treatment for gastric cancer: chemotherapy versus radiation. Oncologist (2013) 1.06
Comparison of the 6th and 7th editions of the AJCC/UICC TNM staging system for gastric cancer focusing on the "N" parameter-related survival: the monoinstitutional NodUs Italian study. World J Surg Oncol (2015) 0.96
Genomic alterations and molecular subtypes of gastric cancers in Asians. Chin J Cancer (2016) 0.93
Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment. World J Gastroenterol (2014) 0.92
Differences in HER2 over-expression between proximal and distal gastric cancers in the Chinese population. World J Gastroenterol (2013) 0.91
Improving the outcomes in gastric cancer surgery. World J Gastroenterol (2014) 0.90
Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy. Radiat Oncol (2012) 0.87
Gastric cancer: Current status of lymph node dissection. World J Gastroenterol (2016) 0.87
Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis. Int J Radiat Oncol Biol Phys (2013) 0.86
Role of robot-assisted distal gastrectomy compared to laparoscopy-assisted distal gastrectomy in suprapancreatic nodal dissection for gastric cancer. Surg Endosc (2015) 0.85
Endoluminal surgical triangulation: overcoming challenges of colonic endoscopic submucosal dissections using a novel flexible endoscopic surgical platform: feasibility study in a porcine model. Surg Endosc (2013) 0.80
Advanced gastric cancer: is there enough evidence to call second-line therapy standard? World J Gastroenterol (2012) 0.79
Ramucirumab: successfully targeting angiogenesis in gastric cancer. Clin Cancer Res (2014) 0.79
Measuring patient-reported outcomes in advanced gastric cancer. Ecancermedicalscience (2013) 0.78
MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer. PLoS One (2016) 0.78
Significant differences in the clinicopathological characteristics and survival of gastric cancer patients from two cancer centers in china and Korea. J Gastric Cancer (2015) 0.77
P115 promotes growth of gastric cancer through interaction with macrophage migration inhibitory factor. World J Gastroenterol (2013) 0.76
Laparoscopic robotic total gastrectomy. Wideochir Inne Tech Maloinwazyjne (2014) 0.75
Subtotal gastrectomy with conventional D2 lymphadenectomy for carcinoma of the distal gastric portion: A retrospective cohort study on clinical outcomes. Ann Med Surg (Lond) (2016) 0.75
Locally advanced gastroesophageal junction tumor: a treatment dilemma. Oncologist (2015) 0.75
Up-regulation of CRKL by microRNA-335 methylation is associated with poor prognosis in gastric cancer. Cancer Cell Int (2017) 0.75
Efficacy of olanzapine in symptom relief and quality of life in gastric cancer patients receiving chemotherapy. J Res Med Sci (2016) 0.75
Efficacy and toxicity of salvage weekly paclitaxel chemotherapy in non-Asian patients with advanced oesophagogastric adenocarcinoma. Ther Adv Med Oncol (2016) 0.75
Clinical characteristics of hepatoduodenal lymph node metastasis in gastric cancer. World J Gastroenterol (2015) 0.75
Bioengineering the gut: future prospects of regenerative medicine. Nat Rev Gastroenterol Hepatol (2016) 0.75
Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients. PLoS One (2017) 0.75
Examining the gastric cancer survival gap between Asians and whites in the United States. Gastric Cancer (2016) 0.75
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med (2006) 26.37
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med (2001) 18.77
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med (2007) 12.62
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med (2008) 9.00
Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet (1997) 7.59
Extended lymph-node dissection for gastric cancer. N Engl J Med (1999) 7.43
Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer (1999) 6.76
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol (2010) 6.60
Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol (2011) 6.53
Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol (2004) 6.47
Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol (2006) 4.38
Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer (2009) 4.04
Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol (2005) 3.63
Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol (2003) 3.56
Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg (2010) 2.99
Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. J Clin Oncol (2003) 2.27
Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center. J Clin Oncol (2003) 2.17
Longterm outcomes after endoscopic mucosal resection for early gastric cancer. Gastric Cancer (2006) 1.83
Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Br J Surg (2007) 1.73
Predictive factors for surgical complications of laparoscopy-assisted distal gastrectomy for gastric cancer. Surg Endosc (2008) 1.64
Is gastric carcinoma different between Japan and the United States? Cancer (2000) 1.61
EMR for early gastric cancer in Korea: a multicenter retrospective study. Gastrointest Endosc (2007) 1.59
Effects of obesity in rectal cancer surgery. J Am Coll Surg (2010) 1.56
Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br J Surg (1993) 1.40
Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer (1993) 1.33
Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates. Cancer (2000) 1.33
Tissue-engineered small intestine and stomach form from autologous tissue in a preclinical large animal model. J Surg Res (2009) 1.30
Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer (2003) 1.22
Impact of lymphovascular invasion in patients with stage I gastric cancer. Surgery (2009) 1.00
Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease location and individual patient comorbidity. Eur J Surg Oncol (2002) 0.98
Evaluation of gastric biopsies for neoplasia: differences between Japanese and Western pathologists. Am J Surg Pathol (1999) 0.98
Effects of sex and racial/ethnic group on the pattern of gastric cancer localization. Gastric Cancer (2002) 0.97
Asian gastric cancer patients at a southern California comprehensive cancer center are diagnosed with less advanced disease and have superior stage-stratified survival. Am Surg (2000) 0.95
Cancer survival discrepancies in developed and developing countries: comparisons between the Philippines and the United States. Br J Cancer (2009) 0.88
Surgical treatment of gastric cancer detected by mass screening. Hepatogastroenterology (1997) 0.88
Biology versus terminology: East meets West in surgical pathology. Gastrointest Endosc (2003) 0.88
Optical properties of human amniotic fluid: implications for videofetoscopic surgery. Fetal Diagn Ther (2009) 0.79
Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2013) 3.03
Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Ann Surg (2012) 2.23
Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. J Clin Oncol (2008) 1.97
Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol (2010) 1.85
Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison. Ann Surg Oncol (2011) 1.69
Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Canc Netw (2015) 1.52
Surgical management of adrenal metastases. J Surg Oncol (2013) 1.10
124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET. J Nucl Med (2011) 1.08
Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer. Ann Surg Oncol (2012) 1.03
Staging laparoscopy in the management of gastric cancer: a population-based analysis. J Am Coll Surg (2011) 1.02
Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma. Ann Surg Oncol (2014) 1.01
Internal hernia after gastrectomy for cancer with Roux-Y reconstruction. Surgery (2013) 1.00
Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 0.99
Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma. Ann Surg (2016) 0.98
Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor. Ann Surg Oncol (2012) 0.97
Minimally invasive surgery for gastric cancer. J Surg Oncol (2012) 0.93
Treatment and outcome of patients with gastric remnant cancer after resection for peptic ulcer disease. Ann Surg Oncol (2010) 0.91
Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers. Ann Surg Oncol (2013) 0.90
Is gastric cancer different in Korea and the United States? Impact of tumor location on prognosis. Ann Surg Oncol (2014) 0.88
Adrenocortical carcinoma: the influence of large vessel extension. Surgery (2010) 0.88
Prospective evaluation of laparoscopic celiac plexus block in patients with unresectable pancreatic adenocarcinoma. Ann Surg Oncol (2010) 0.88
Esophageal reinforcement with an extracellular scaffold during total gastrectomy for gastric cancer. Ann Surg Oncol (2014) 0.86
Defining surgical indications for type I gastric carcinoid tumor. Ann Surg Oncol (2009) 0.86
Imaging and management of a small cell lung cancer metastasis/adrenal adenoma collision tumor: a case report and review of the literature. World J Surg Oncol (2014) 0.79
An analysis of the utility of handheld PET probes for the intraoperative localization of malignant tissue. J Gastrointest Surg (2010) 0.79
Laparoscopic transabdominal lateral adrenalectomy. J Surg Oncol (2012) 0.77
Current role of therapeutic laparoscopy and thoracoscopy in the management of malignancy: a review of trends from a tertiary care cancer center. J Am Coll Surg (2007) 0.77
Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy. Ann Surg Oncol (2012) 0.77
The current status of laparoscopic adrenalectomy. Adv Surg (2007) 0.77
The role of minimal access surgery for metastasectomy and cytoreduction. Surg Oncol Clin N Am (2007) 0.76
Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Indian J Surg Oncol (2011) 0.76
Adjuvant and neoadjuvant therapy for gastric cancer: taking stock of the options. Gastrointest Cancer Res (2012) 0.75
Novel handheld PET probes provide intraoperative localization of PET-avid lymph nodes. Surg Endosc (2011) 0.75
The new era of gastric cancer in the East and West: have our approaches harmonized? Dig Surg (2013) 0.75
Lauren Histologic Type Is the Most Important Factor Associated With Pattern of Recurrence Following Resection of Gastric Adenocarcinoma. Ann Surg (2016) 0.75
Gastrectomy for cancer: What are the benefits of a minimally invasive approach? Bull Am Coll Surg (2017) 0.75
A new approach for advanced gastric cancer: Using PET scans as a biomarker of preoperative chemotherapy efficacy. Bull Am Coll Surg (2017) 0.75